HIF-1α and GLUT1 Gene Expression is Associated with Chemoresistance of Acute Myeloid Leukemia |
Song, Kui
(Department of Hematology, Nanfang Hospital of Southern Medical University)
Li, Min (Department of Pharmacy, The First Affiliated Hospital of Jishou University) Xu, Xiao-Jun (Department of Hematology, Nanfang Hospital of Southern Medical University) Xuan, Li (Department of Hematology, Nanfang Hospital of Southern Medical University) Huang, Gui-Nian (Department of Hematology, Zhongshan City People's Hospital) Song, Xiao-Ling (Department of Hematology, Nanfang Hospital of Southern Medical University) Liu, Qi-Fa (Department of Hematology, Nanfang Hospital of Southern Medical University) |
1 | Huang XD, Wang ZF, Dai LM, et al (2012). Microarray analysis of the hypoxia-induced gene expression profile in malignant C6 glioma cells. Asian Pac J Cancer Prev, 13, 4793-9. DOI ScienceOn |
2 | Hao J, Song X, Song B, et al (2008). Effects of lentivirusmediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells. Cancer Gene Ther, 15, 449-55. DOI ScienceOn |
3 | Herst PM, Howman RA, Neeson PJ, et al (2011). The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome. J Leukoc Biol, 89, 51-5. DOI ScienceOn |
4 | Hu Y, Kirito K, Yoshida K, et al (2009). Inhibition of hypoxiainducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan. Mol Cancer Ther, 8, 2329-38. |
5 | Hulleman E, Kazemier KM, Holleman A, et al (2009). Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood, 113, 2014-21. DOI ScienceOn |
6 | Kluza J, Jendoubi M, Ballot C, et al (2011). Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells. PLoS One, 6, e21924. DOI |
7 | Kominsky DJ, Klawitter J, Brown JL, et al (2009). Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells. Clin Cancer Res, 15, 3442-50. DOI ScienceOn |
8 | Lu CW, Lin SC, Chen KF, et al (2008). Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J Biol Chem, 283, 28106-14. DOI ScienceOn |
9 | Manel N, Battini JL, Sitbon M (2005). Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1. J Biol Chem, 280, 29025-9. DOI ScienceOn |
10 | Takubo K, Goda N, Yamada W, et al (2010). Regulation of the HIF-1a level is essential for hematopoietic stem cells. Cell Stem Cell, 7, 391-402. DOI ScienceOn |
11 | Tamada M, Nagano O, Tateyama S, et al (2012). Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. Cancer Res, 72, 1438-48. DOI ScienceOn |
12 | Wynn ML, Merajver SD, Schnell S (2012). Unraveling the complex regulatory relationships between metabolism and signal transduction in cancer. Adv Exp Med Biol, 736, 179-89. DOI |
13 | Zhou Y, Tozzi F, Chen J, et al (2012). Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Cancer Res, 72, 304-14. DOI ScienceOn |
14 | Zhou Y, Tozzi F, Chen J, et al (2012). Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Cancer Res, 72, 304-14. DOI ScienceOn |
15 | Papageorgis P, Cheng K, Ozturk S, et al (2011). Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Res, 71, 998-1008. DOI ScienceOn |
16 | Chinese Chemotherapy Symposium of Leukemia (1988). The chemotherapy response criteria of acute leukemia. Chin J Hematol, 9, 183-4. |
17 | Chen EI (2012). Mitochondrial dysfunction and cancer metastasis. J Bioenerg Biomembr, 44, 619-22. DOI ScienceOn |
18 | Buentke E, Nordstrom A, Lin H, et al (2011). Glucocorticoidinduced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells. Blood Cancer J, 1, e31. DOI ScienceOn |
19 | Chen CY, Jia JH, Zhang MX, et al (2005). Proteomic analysis on multi-drug resistant cells HL-60/DOX of acute myeloblastic leukemia. Chin J Physiol, 48, 115-20. |
20 | Chung FY, Huang MY, Yeh CS, et al (2009). GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer, 9, 241. DOI ScienceOn |
21 | Comito G, Calvani M, Giannoni E, et al (2011). HIF-1 stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic Biol Med, 51, 893-904. DOI ScienceOn |
22 | Deeb G, Vaughan MM, McInnis I, et al (2011). Hypoxiainducible factor-1 protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia. Leuk Res, 35, 579-84. DOI ScienceOn |
23 | Deeb G, Vaughan MM, McInnis I, et al (2011). Hypoxiainducible factor-1 protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia. Leuk Res, 35, 579-84. DOI ScienceOn |
24 | Amann T, Maegdefrau U, Hartmann A, et al (2009). GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol, 174, 1544-52. DOI ScienceOn |
25 | Pelicano H, Martin DS, Xu RH, et al (2006). Glycolysis inhibition for anticancer treatment. Oncogene, 25, 4633-46. DOI ScienceOn |
26 | Bayley JP, Devilee P (2012). The Warburg effect in 2012. Curr Opin Oncol, 24, 62-7. DOI ScienceOn |
27 | Matsunaga T, Imataki O, Torii E, et al (2012). Elevated HIF- 1 expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy. Leuk Res, 36, e122-4. DOI ScienceOn |
28 | Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, et al (2007). Energy metabolism in tumor cells. FEBS J, 274, 1393-418. DOI ScienceOn |
29 | Nakajima EC, Van Houten B (2013). Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol Carcinog, 52, 329-37. DOI ScienceOn |
30 | Patiar S, Harris AL (2006). Role of hypoxia-inducible factor- 1alpha as a cancer therapy target. Endocr Relat Cancer, 13, S61-75. DOI ScienceOn |
31 | Robey IF, Lien AD, Welsh SJ, et al (2005). Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia, 7, 324-30. DOI |
32 | Saigusa S, Toiyama Y, Tanaka K, et al (2012). Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy. Surg Today, 42, 460-9. DOI ScienceOn |
33 | Song X, Liu X, Chi W, et al (2006). Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol, 58, 776-84. DOI ScienceOn |
34 | Suh DH, Kim MK, No JH, et al (2011). Metabolic approaches to overcoming chemoresistance in ovarian cancer. Ann N Y Acad Sci, 1229, 53-60. DOI ScienceOn |
35 | Amann T, Hellerbrand C (2009). GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets, 13, 1411-27. DOI ScienceOn |
36 | Cao X, Fang L, Gibbs S, et al (2007). Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother Pharmacol, 59, 495-505. DOI |